Biotalys NV (BR:BTLS) — Stock Price
Biotalys NV (BR:BTLS) is currently trading at €2.56 EUR, down 2.85% today. Over the past 52 weeks, shares have ranged between €1.66 and €5.24. This page tracks Biotalys NV's live share price on the BR exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market value of Biotalys NV.
Biotalys NV (BTLS) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Biotalys NV's daily closing share price and trading volume on the BR exchange over the past year, giving a clear view of recent price momentum and liquidity.
Biotalys NV Income Statement — Revenue, Profit & Earnings by Year
Biotalys NV's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Research & Development | €11.01 Million | €16.66 Million | €18.81 Million | €13.88 Million | €11.49 Million |
| SG&A | €5.72 Million | €5.71 Million | €5.08 Million | €4.91 Million | €2.35 Million |
| Total Operating Expenses | €13.49 Million | €20.89 Million | €22.53 Million | €18.08 Million | €13.28 Million |
| Operating Income | €-13.49 Million | €-20.89 Million | €-22.53 Million | €-18.08 Million | €-13.28 Million |
| EBITDA | €-12.35 Million | €-19.51 Million | €-20.95 Million | €-16.77 Million | €-13.01 Million |
| EBIT | €-13.49 Million | €-20.89 Million | €-22.52 Million | €-17.58 Million | €-13.28 Million |
| Interest Expense | €157.00K | €161.00K | €247.00K | €246.00K | €86.00K |
| Income Before Tax | €-13.15 Million | €-20.45 Million | €-22.77 Million | €-16.91 Million | €-10.74 Million |
| Income Tax Expense | €40.00K | €56.00K | €-38.00K | €16.00K | €13.00K |
| Net Income | €-13.19 Million | €-20.51 Million | €-22.73 Million | €-16.93 Million | €-10.75 Million |
Biotalys NV Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Biotalys NV's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | €36.75 Million | €36.58 Million | €49.52 Million | €70.27 Million | €36.26 Million |
| Total Current Assets | €26.24 Million | €24.91 Million | €37.76 Million | €58.94 Million | €25.50 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | €2.10 Million |
| Net Receivables | €435.00K | — | €820.00K | €451.00K | €226.00K |
| Inventory | — | — | — | — | — |
| Property, Plant & Equipment | — | — | €9.00 Million | €9.29 Million | €8.96 Million |
| Goodwill | — | — | — | — | — |
| Total Liabilities | €9.14 Million | €11.01 Million | €11.40 Million | €11.36 Million | €10.61 Million |
| Total Current Liabilities | €4.77 Million | €5.55 Million | €5.96 Million | €5.21 Million | €6.15 Million |
| Long-term Debt | — | — | — | €6.04 Million | €4.33 Million |
| Net Debt | €-22.64 Million | €-15.50 Million | €-27.59 Million | €-48.88 Million | €-17.88 Million |
| Total Stockholder Equity | €27.61 Million | €25.57 Million | €38.11 Million | €58.91 Million | €25.65 Million |
| Retained Earnings | €-11.72 Million | €-40.20 Million | €-19.66 Million | €-55.85 Million | €-34.12 Million |
Biotalys NV Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Biotalys NV generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | €-12.65 Million | €-18.28 Million | €-20.09 Million | €-16.75 Million | €-9.53 Million |
| Capital Expenditures | €138.00K | €455.00K | €707.00K | €1.33 Million | €3.93 Million |
| Free Cash Flow | €-12.79 Million | €-18.74 Million | €-20.80 Million | €-18.09 Million | €-13.46 Million |
| Investing Cash Flow | €577.00K | €233.00K | €-684.00K | €-1.32 Million | €-6.02 Million |
| Financing Cash Flow | €13.14 Million | €5.53 Million | €-1.24 Million | €51.08 Million | €15.29 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | €658.00K | €1.04 Million | €1.73 Million | €511.00K | €550.00K |
| Depreciation | €1.83 Million | €1.78 Million | €1.57 Million | €1.47 Million | €1.04 Million |
| Change in Cash | €1.07 Million | €-12.53 Million | €-22.01 Million | €33.00 Million | €-255.00K |
Biotalys NV Earnings History — EPS Actual vs. Analyst Estimates
Track Biotalys NV's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Mar 12, 2026 | — | — | — |
| Sep 18, 2025 | -0.22 | — | — |
| Apr 23, 2025 | — | — | — |
| Mar 18, 2025 | -0.20 | 0.00 | — |
| Feb 28, 2023 | -0.74 | 0.00 | — |
| Aug 19, 2022 | -0.32 | 0.00 | — |
| Mar 11, 2022 | -0.55 | 0.00 | — |
| Dec 08, 2021 | -0.11 | 0.00 | — |